SCHEMBL19682380

SCHEMBL19682380

CC1(C)CC(=O)c2cccc(Br)c2O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
TRPM8 Q7Z2W7 2/20 0.42
MAOB P27338 7/20 0.41
PIM1 P11309 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CDK5 Q00535 1/20 0.38
ROCK1 Q13464 1/20 0.38
DYRK1A Q13627 1/20 0.38
LRRK2 Q5S007 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
PARP10 Q53GL7 1/20 0.36
PARP11 Q9NR21 1/20 0.36
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31111205 1.00 KDM4E (0.43) KDM4EALDH1A1MAPTTRPM8MAOB
SCHEMBL2321465 0.80 MAOB (0.45) KDM4EALDH1A1MAPTTRPM8MAOB
SCHEMBL16335003 0.79 KDM4E (0.45) KDM4EALDH1A1MAPTMAOBCNR1
SCHEMBL8316228 0.78 HTR1A (0.39) KDM4EALDH1A1MAPTTRPM8PIM1
SCHEMBL2319912 0.76 KMT2A (0.41) KDM4EALDH1A1MAPTTRPM8MAOB
SCHEMBL8897383 0.75 LMNA (0.48) KDM4EALDH1A1MAPTLMNA
SCHEMBL20889275 0.75 CHRM2 (0.41) KDM4EALDH1A1MAPTMAOBCNR1
SCHEMBL30694907 0.74 ALDH1A1 (0.38) ALDH1A1PIM1CSNK1A1CDK5ROCK1
SCHEMBL21503789 0.74 ALDH1A1 (0.38) ALDH1A1PIM1CSNK1A1CDK5ROCK1
SCHEMBL30609093 0.73 ALDH1A1 (0.46) KDM4EALDH1A1MAPTMAOBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023201012-A1 IKZF2 DEGRADERS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-10-19 WO disclosed
US-10889555-B2 Sulfonamide compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-01-12 US disclosed
US-20200405697-A1 Antitumor Agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-31 US disclosed
US-20200399235-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
EP-3718545-A1 ANTITUMOR AGENT Taiho Pharmaceutical Co., Ltd. (JP) 2020-10-07 EP disclosed
US-20200157066-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-05-21 US disclosed
EP-3466934-A1 SULFONAMIDE COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2019-04-10 EP disclosed
WO-2017209155-A1 SULFONAMIDE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399235-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 KDM4E 1551/4885ALDH1A1 1103/4885MAPT 4312/4885
US-20200157066-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 KDM4E 1551/4885ALDH1A1 1103/4885MAPT 4312/4885
US-10889555-B2 Sulfonamide compound or salt thereof RNASEH1, SNRPA1, RRM2 KDM4E 1551/4885ALDH1A1 1103/4885MAPT 4312/4885
US-20200405697-A1 Antitumor Agent HNRNPR, RRM2, RRM2B KDM4E 2851/4885ALDH1A1 1397/4885MAPT 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.